Large B-Cell Lymphomas Poor in B Cells and Rich in PD-1+ T Cells Can Mimic T-Cell Lymphomas

被引:14
作者
Ohgami, Robert S. [1 ]
Zhao, Shuchun [1 ]
Natkunam, Yasodha [1 ]
机构
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
关键词
T-cell histiocyte rich large B-cell lymphoma; PD-1+T cells; Large B-cell lymphoma; PREDOMINANT HODGKIN LYMPHOMA; PD-L1; EXPRESSION; PATTERNS; IMMUNOGLOBULIN; LOCALIZATION; SURVIVAL;
D O I
10.1309/AJCPFJWKQ6GTVQE6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: To characterize the clinicopathologic features of cases of large B-cell lymphomas, poor in B cells and densely rich in programmed cell death-1 (PD-1)+ reactive T cells, which can mimic T-cell lymphomas. Methods: A single-institute retrospective review of cases between 2010 and 2013 was performed. Results: Of 178 cases of large B-cell lymphomas, eight cases of large B-cell lymphomas poor in B cells and diffusely rich in sheets of PD-1+ T cells were identified. These cases either were initially misdiagnosed as a T-cell lymphoma or substantiated a broader differential diagnosis including a T-cell lymphoma. Five cases were T-cell histiocyte rich large B-cell lymphomas, and three cases were diagnosed as large B-cell lymphomas rich in T cells. In three of these cases, a subset of the PD-1+ T cells showed either morphologic nuclear atypia or atypical expression of T-cell antigens on flow cytometry and/or immunohistochemistry. Conclusions: Large B-cell lymphomas poor in B cells and rich in T cells can have diffuse sheets of reactive PD-1+ T cells, some with atypical morphologic and immunophenotypic features mimicking a T-cell lymphoma. Careful assessment of the immunoarchitecture and background inflammatory and stromal cells can prevent erroneous diagnoses in such cases.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 23 条
[1]   PD-L1 Expression in B-cell Lymphomas and Virus-Associated Malignancies-Letter [J].
Andersen, Mads Hald .
CLINICAL CANCER RESEARCH, 2013, 19 (14) :4017-4017
[2]   Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells [J].
Andorsky, David J. ;
Yamada, Reiko E. ;
Said, Jonathan ;
Pinkus, Geraldine S. ;
Betting, David J. ;
Timmerman, John M. .
CLINICAL CANCER RESEARCH, 2011, 17 (13) :4232-4244
[3]  
Batra R, 2012, APPL IMMUNOHISTO M M, V20, P325, DOI 10.1097/PAI.0b013e318233d72a
[4]   Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 [J].
Brueggemann, M. ;
White, H. ;
Gaulard, P. ;
Garcia-Sanz, R. ;
Gameiro, P. ;
Oeschger, S. ;
Jasani, B. ;
Ott, M. ;
Delsol, G. ;
Orfao, A. ;
Tiemann, M. ;
Herbst, H. ;
Langerak, A. W. ;
Spaargaren, M. ;
Moreau, E. ;
Groenen, P. J. T. A. ;
Sambade, C. ;
Foroni, L. ;
Carter, G. I. ;
Hummel, M. ;
Bastard, C. ;
Davi, F. ;
Delfau-Larue, M. -H. ;
Kneba, M. ;
van Dongen, J. J. M. ;
Beldjord, K. ;
Molina, T. J. .
LEUKEMIA, 2007, 21 (02) :215-221
[5]   High Numbers of Tumor-Infiltrating Programmed Cell Death 1-Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma [J].
Carreras, Joaquim ;
Lopez-Guillermo, Armando ;
Roncador, Giovanna ;
Villamor, Neus ;
Colomo, Lluis ;
Martinez, Antonio ;
Hamoudi, Rifat ;
Howat, William J. ;
Montserrat, Emili ;
Campo, Elias .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1470-1476
[6]   PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies [J].
Chen, Benjamin J. ;
Chapuy, Bjoern ;
Jing Ouyang ;
Sun, Heather H. ;
Roemer, Margaretha G. M. ;
Xu, Mina L. ;
Yu, Hongbo ;
Fletcher, Christopher D. M. ;
Freeman, Gordon J. ;
Shipp, Margaret A. ;
Rodig, Scott J. .
CLINICAL CANCER RESEARCH, 2013, 19 (13) :3462-3473
[7]   Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis [J].
Churchill, Hywyn R. O. ;
Roncador, Giovanna ;
Warnke, Roger A. ;
Natkunam, Yasodha .
HUMAN PATHOLOGY, 2010, 41 (12) :1726-1734
[8]   Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma [J].
Dorfman, DM ;
Brown, JA ;
Shahsafaei, A ;
Freeman, GJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) :802-810
[9]   T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower bcl-2 expression than diffuse large-B-cell lymphomas [J].
Felgar, RE ;
Steward, KR ;
Cousar, JB ;
Macon, WR .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (06) :1707-1715
[10]   PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells [J].
Good-Jacobson, Kim L. ;
Szumilas, Courtney G. ;
Chen, Lieping ;
Sharpe, Arlene H. ;
Tomayko, Mary M. ;
Shlomchik, Mark J. .
NATURE IMMUNOLOGY, 2010, 11 (06) :535-U107